×
Back to Agenda
Orphan Drugs and Treatment of Rare Diseases in Asia
Session Chair(s)
Noriaki Murao, DIAFellow, MS
Senior Consultant (Pharmaceuticals), NM Consulting, Japan
Developing Treatments of Rare Diseases in Asia
Learning Objective : Discuss the current epidemiology and developments of rare diseases in Asia including how these achievements affect other countries; Describe the orphan drug legislation and status of orphan drug development in Japan.
Speaker(s)
Hiroshi Mizushima, PHD
Chief Senior Researcher, Center for Public Health Informatics, National Institute of Public Health, Japan
Government Challenges and Initiatives on Rare Diseases in Asia
Wuh-Liang Hwu, MD, PHD
Professor in Pediatrics, National Taiwan University, Taiwan
Developing Treatments of Rare Diseases in Asia
Harumasa Nakamura, MD, PHD
Director of Department of Clinical Research Support, , National Center of Neurology and Psychiatry, Japan
Japanese Regulation on Orphan Medicines and Drug Development in Rare Diseases
Have an account?